OTLKW

Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022

Delisted

OTLKW was delisted on the 16th of February, 2022.

4 hedge funds and large institutions have $116K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
2
Closed
2
Calls
$272K
Puts
Net Calls
+$272K
Net Calls Change
-$40K
Name Holding Trade Value Shares
Change
Shares
Change %
CAM
1
Cormorant Asset Management
Massachusetts
$54K -$29.1K -145,968 -35%
SFM
2
Sphera Funds Management
Israel
$26K
PC
3
PointState Capital
New York
$20K
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$16K -$10.5K -51,981 -40%
CIA
5
Compass Ion Advisors
Pennsylvania
-$4K -10,000 Closed